| Hallucinogen persisting perception disorder after psilocybin consumption: a case study. | |
| | |
MedLine Citation:
|
PMID: 15963699 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The recurrence of flashbacks without acute or chronic hallucinogen consumption has been recognized in the DSM IV criteria as the hallucinogen persisting perception disorder (HPPD). Perceptual disturbances may last for 5 years or more and represent a real psychosocial distress. We reported here a case of a 18-year-old young man presenting HPPD after a mixed intoxication with psylocibin and cannabis. This report shows symptomatic recurrences persisting more than 8 months. Various differential diagnoses were evoked and our therapeutic strategies were described. |
| | |
Authors:
|
Marie-Laure Espiard; Laurent Lecardeur; Pascale Abadie; Isabelle Halbecq; Sonia Dollfus |
Related Documents
:
|
17261449 - Esophageal involvement as an initial manifestation of churg-strauss syndrome. 1630429 - Outbreak of type e botulism associated with an uneviscerated, salt-cured fish product--... 7600819 - Corneal subepithelial infiltrate recurrence sine adenovirus. 3291939 - Indomethacin retinopathy: case report and review. 3287239 - Effects of stress on muscarinic mechanisms. 21371779 - Bilateral peritonsillar abscess: case report and literature review. 16924199 - Ventral thoracic spinal cord herniation: frequently misdiagnosed entity. 8740749 - Fatal spontaneous rupture of a gravid uterus: case report and literature review of uter... 1363639 - Xanthomonas maltophilia bacteremia: an analysis of 32 cases. |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: European psychiatry : the journal of the Association of European Psychiatrists Volume: 20 ISSN: 0924-9338 ISO Abbreviation: Eur. Psychiatry Publication Date: 2005 Aug |
Date Detail:
|
Created Date: 2005-09-20 Completed Date: 2006-02-10 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9111820 Medline TA: Eur Psychiatry Country: France |
Other Details:
|
Languages: eng Pagination: 458-60 Citation Subset: IM |
Affiliation:
|
Centre Esquirol, Centre Hospitalier Universitaire de Caen, 14033 Caen cedex, France. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Antidepressive Agents / therapeutic use Antipsychotic Agents / therapeutic use Anxiety / chemically induced, drug therapy, psychology Depressive Disorder / chemically induced, drug therapy, psychology Diagnosis, Differential Hallucinogens / adverse effects* Humans Male Marijuana Smoking Perceptual Disorders / chemically induced*, diagnosis*, drug therapy Psilocybine / adverse effects* Psychiatric Status Rating Scales Recurrence Risperidone / therapeutic use Sertraline / therapeutic use Social Behavior Disorders / chemically induced, drug therapy, psychology Time Factors |
| Chemical | |
Reg. No./Substance:
|
0/Antidepressive Agents; 0/Antipsychotic Agents; 0/Hallucinogens; 106266-06-2/Risperidone; 520-52-5/Psilocybine; 79617-96-2/Sertraline |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Research on mental disorders and their care in immigrant populations: a review of publications from ...
Next Document: Prevalence and incidence of Parkinson's disease in Europe.